Antihypertensive treatment: does the J-curve exist?

L Hansson1

  • 1Clinical Hypertension Research, Department of Public Health and Social Sciences, University of Uppsala, Sweden.

Insights

Lowering blood pressure effectively prevents cardiovascular events in hypertension. However, overly aggressive treatment risks adverse effects due to the J-shaped risk curve, necessitating careful blood pressure management.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Clinical Trials

Background:

  • Current hypertension treatment fails to fully prevent cardiovascular morbidity and mortality.
  • Treated hypertensive patients remain at elevated cardiovascular risk despite therapy.
  • Blood pressure is often not reduced to strictly normotensive levels in treated patients.

Purpose of the Study:

  • To investigate the optimal blood pressure reduction for maximum prevention of hypertension-associated cardiovascular events.
  • To explore the implications of the J-shaped blood pressure-risk relationship in hypertension management.
  • To discuss the rationale and findings of key prospective intervention trials, specifically the HOT Study.

Main Methods:

  • Review of existing literature on blood pressure reduction and cardiovascular outcomes.
  • Analysis of two prospective intervention trials: the Blood Pressure Lowering and Blood Pressure (BBB) Study (1994) and the Hypertension Optimal Treatment (HOT) Study (1998).
  • Focus on the design and results of the HOT Study.

Main Results:

  • The J-shaped relationship indicates that excessive blood pressure lowering can increase cardiovascular risks.
  • The HOT Study provided significant data on achieving target blood pressures and their impact on cardiovascular outcomes.
  • Findings suggest a need for tailored, vigorous blood pressure reduction strategies within safe limits.

Conclusions:

  • Optimal blood pressure reduction is crucial for preventing hypertension-related cardiovascular complications.
  • Vigorous lowering of blood pressure must be balanced against the risks of over-reduction, as suggested by the J-shaped curve.
  • The HOT Study offers valuable insights into optimizing antihypertensive treatment strategies.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.